Curical Technologies Ltd.

Who We Are? Curical is a private start-up founded in 2015 to investigate copper as an antibacterial agent for sutures. Curical enhanced its internal capabilities with key consultants and is honored to also have former Ethicon distinguished researchers / executives on its team. The Power of Copper Copper is a natural antimicrobial agent and an essential element in the human body which facilitates normal metabolic processes. Also, copper has been long used with no known evidence of the emergence of resistant microbial strains. Curical's Technology Our first development is to incorporate copper in a multifilament suture. Sutures are a risk factor to Surgical Site Infection (SSI). SSI is defined as an infection that occurs within 30 days after the operation and involves the skin of the incision3. Foreign materials, such as sutures and especially multifilaments, are a risk factor to SSI as they lower the number of bacteria required to cause an infection4. Therefore adding copper to the suture reduces the microbial colonization of the suture. As of now, Triclosan is the most dominant material used in antibacterial sutures. The World Health Organization gave a conditional recommendation to use triclosan-coated sutures for the purpose of reducing the risk of SSI. It was also written that "..comparisons with an alternative antimicrobial agent to triclosan would be welcome"5. We view copper as an optimal antibacterial agent for sutures. Therefore we are excited to work with several global companies to enter the market with our copper based antibacterial technology.

• Employees 2
• Founded 2015